GlassScriptPhysician profile
Andrew H Schulick
NPI 1043283468
$1,482.55
in general payments reported to CMS, 2019-2025
10 companies · $926 in 2025
The $926 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $98.49 · 2021: $19.64 · 2022: $151 · 2023: $95.76 · 2024: $40.16 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $731 · Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $730.74 |
| Food and Beverage | $331.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $835.05 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $195.95 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $174.29 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Angiojet Ultra 5000a, Eluvia |
| Bard Peripheral Vascular, INC. | $137.17 | 2019 | |
| Cook Medical LLC | $33.86 | 2022 | |
| Terumo Medical Corporation | $26.02 | 2022 | |
| Medtronic, INC. | $25.80 | 2022 | |
| W. L. Gore & Associates, INC. | $24.22 | 2022 | |
| Abbott Laboratories | $15.44 | 2023 | Perclose Prostyle |
| Ekos Corporation | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schulick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.